Takara Bio USA collaborates with Illumina on a single-cell-resolution spatial mapping workflow, presented at AGBT 2026.

Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

Studying gene expression in a cancer patient's cells can help clinical biologists understand the cancer's origin and predict the success of different treatments. But cells are complex and contain many ...

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' spatial context.

Studying gene expression in a cancer patient's cells can help clinical biologists understand the cancer's origin and predict ...

Endometrial cancer (EC) incidence is rising globally, yet therapeutic progress has lagged behind other solid tumors, in part due to the complexity and ...

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

Figuring out who to screen could change the game. This discovery is getting us closer.

Ahead of AGBT, Ultima Genomics launched its UG200 series touting smaller footprint, faster runtime, higher output, and lower pricing.

Bruker now extends their complete biology approach to mouse research by announcing development of the CosMx Mouse Whole Transcriptome (WTX) assay. The mouse WTX assay will be available for both FFPE ...

With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...